多模态MRI影像组学增强儿童低级别胶质瘤患者癫痫预测
本研究基于术前多参数MRI提取肿瘤及瘤周影像组学特征,构建机器学习与深度学习框架预测儿童低级别胶质瘤患者肿瘤相关癫痫,多模态MRI影像组学模型AUC达0.969,多序列MRI数据整合显著提升预测性能,SGD分类器灵敏度0.882、特异度0.956。
要点
- 多模态MRI影像组学模型预测儿童低级别胶质瘤相关癫痫的AUC为0.969。
- 多序列MRI数据整合显著提升预测性能,SGD分类器灵敏度0.882、特异度0.956。
- 模型可准确预测肿瘤相关癫痫,有望指导手术决策。
核心结论
- 多模态MRI影像组学模型能准确预测儿童低级别胶质瘤患者是否存在肿瘤相关癫痫,可指导手术决策。
研究设计与样本
- 本研究提出一种基于影像组学的新方法,整合术前多参数MRI提取的肿瘤与瘤周特征,用于无创预测儿童低级别胶质瘤患者的肿瘤相关癫痫。
主要发现
- 多模态MRI影像组学模型预测儿童低级别胶质瘤患者癫痫的AUC为0.969。
- 整合多序列MRI数据显著提升预测性能,随机梯度下降(SGD)分类器灵敏度0.882、特异度0.956。
临床怎么用
- 作者认为该模型可准确预测儿童低级别胶质瘤患者是否存在肿瘤相关癫痫,从而指导手术决策。
- 作者建议未来研究应聚焦于在儿童癫痫中心开展类似的标准化术前评估,以增加训练数据并提升模型泛化能力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Determining whether pediatric patients with low-grade gliomas (pLGGs) have tumor-related epilepsy (GAE) is a crucial aspect of preoperative evaluation. Therefore, we aim to propose an innovative, machine learning- and deep learning-based framework for the rapid and non-invasive preoperative assessment of GAE in pediatric patients using magnetic resonance imaging (MRI). METHODS: In this study, we propose a novel radiomics-based approach that integrates tumor and peritumoral features extracted from preoperative multiparametric MRI scans to accurately and non-invasively predict the occurrence of tumor-related epilepsy in pediatric patients. RESULTS: Our study developed a multimodal MRI radiomics model to predict epilepsy in pLGGs patients, achieving an AUC of 0.969. The integration of multi-sequence MRI data significantly improved predictive performance, with Stochastic Gradient Descent (SGD) classifier showing robust results (sensitivity: 0.882, specificity: 0.956). CONCLUSION: Our model can accurately predict whether pLGGs patients have tumor-related epilepsy, which could guide surgical decision-making. Future studies should focus on similarly standardized preoperative evaluations in pediatric epilepsy centers to increase training data and enhance the generalizability of the model.
引用
- Tang T, Wu Y, Dong X, et al. Multimodal MRI radiomics enhances epilepsy prediction in pediatric low-grade glioma patients. J Neurooncol. 2025. PMID: 40402200. doi:10.1007/s11060-025-05073-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。